nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Pancreatitis—Prednisolone—ankylosing spondylitis	0.00609	0.00609	CcSEcCtD
Doxylamine—Sweating increased—Prednisolone—ankylosing spondylitis	0.00605	0.00605	CcSEcCtD
Doxylamine—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.00595	0.00595	CcSEcCtD
Doxylamine—Affect lability—Dexamethasone—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Doxylamine—Affect lability—Betamethasone—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Doxylamine—Irritability—Dexamethasone—ankylosing spondylitis	0.00572	0.00572	CcSEcCtD
Doxylamine—Irritability—Betamethasone—ankylosing spondylitis	0.00572	0.00572	CcSEcCtD
Doxylamine—Mood swings—Betamethasone—ankylosing spondylitis	0.00568	0.00568	CcSEcCtD
Doxylamine—Mood swings—Dexamethasone—ankylosing spondylitis	0.00568	0.00568	CcSEcCtD
Doxylamine—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Doxylamine—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Doxylamine—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.00558	0.00558	CcSEcCtD
Doxylamine—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00556	0.00556	CcSEcCtD
Doxylamine—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.00555	0.00555	CcSEcCtD
Doxylamine—Affect lability—Prednisone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Doxylamine—Bradycardia—Prednisolone—ankylosing spondylitis	0.00506	0.00506	CcSEcCtD
Doxylamine—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00505	0.00505	CcSEcCtD
Doxylamine—Sweating increased—Betamethasone—ankylosing spondylitis	0.00505	0.00505	CcSEcCtD
Doxylamine—Irritability—Prednisone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Doxylamine—Polyuria—Methotrexate—ankylosing spondylitis	0.00497	0.00497	CcSEcCtD
Doxylamine—Mood swings—Prednisone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Doxylamine—Sweating—Methylprednisolone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Doxylamine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Doxylamine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00464	0.00464	CcSEcCtD
Doxylamine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Doxylamine—Pancreatitis—Prednisone—ankylosing spondylitis	0.00442	0.00442	CcSEcCtD
Doxylamine—Sweating increased—Prednisone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Doxylamine—Erythema—Prednisolone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Doxylamine—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00426	0.00426	CcSEcCtD
Doxylamine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Doxylamine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Doxylamine—Bradycardia—Betamethasone—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Doxylamine—Irritability—Methotrexate—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Doxylamine—Mood swings—Methotrexate—ankylosing spondylitis	0.00413	0.00413	CcSEcCtD
Doxylamine—Hallucination—Dexamethasone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Doxylamine—Hallucination—Betamethasone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Doxylamine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Doxylamine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Doxylamine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Doxylamine—Depression—Prednisone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Doxylamine—Erythema—Triamcinolone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Doxylamine—Erythema—Methylprednisolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Doxylamine—Angioedema—Prednisolone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Doxylamine—Breast disorder—Methotrexate—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Doxylamine—Malaise—Prednisolone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Doxylamine—Vertigo—Prednisolone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Doxylamine—Eye disorder—Betamethasone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Doxylamine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Doxylamine—Convulsion—Prednisolone—ankylosing spondylitis	0.00375	0.00375	CcSEcCtD
Doxylamine—Pancreatitis—Methotrexate—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Doxylamine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Doxylamine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Doxylamine—Bradycardia—Prednisone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Doxylamine—Discomfort—Prednisolone—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Doxylamine—Angioedema—Triamcinolone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Doxylamine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Doxylamine—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Doxylamine—Erythema—Dexamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Doxylamine—Erythema—Betamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Doxylamine—Hallucination—Prednisone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Doxylamine—Malaise—Triamcinolone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Doxylamine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Doxylamine—Malaise—Methylprednisolone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Doxylamine—Vertigo—Triamcinolone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Doxylamine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Doxylamine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00353	0.00353	CcSEcCtD
Doxylamine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Doxylamine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Doxylamine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Doxylamine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Doxylamine—Eye disorder—Prednisone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Doxylamine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Doxylamine—Drowsiness—Methotrexate—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Doxylamine—Depression—Methotrexate—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Doxylamine—Flushing—Prednisone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Doxylamine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Doxylamine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Doxylamine—Discomfort—Triamcinolone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Doxylamine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Doxylamine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Doxylamine—Angioedema—Dexamethasone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Doxylamine—Angioedema—Betamethasone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Doxylamine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Doxylamine—Immune system disorder—Prednisone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Doxylamine—Malaise—Dexamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Doxylamine—Malaise—Betamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Doxylamine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Doxylamine—Vertigo—Dexamethasone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Doxylamine—Vertigo—Betamethasone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Doxylamine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Doxylamine—Sweating—Methotrexate—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Doxylamine—Insomnia—Prednisolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Doxylamine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Doxylamine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Doxylamine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Doxylamine—Erythema—Prednisone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Doxylamine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Doxylamine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Doxylamine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Doxylamine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Doxylamine—Convulsion—Betamethasone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Doxylamine—Anxiety—Betamethasone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Doxylamine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Doxylamine—Discomfort—Dexamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Doxylamine—Discomfort—Betamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Doxylamine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Doxylamine—Hepatitis—Methotrexate—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Doxylamine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Doxylamine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Doxylamine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Doxylamine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Doxylamine—Insomnia—Triamcinolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Doxylamine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Doxylamine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Doxylamine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Doxylamine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Doxylamine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Doxylamine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Doxylamine—Agitation—Prednisone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Doxylamine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Doxylamine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Doxylamine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Doxylamine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Doxylamine—Angioedema—Prednisone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Doxylamine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Doxylamine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Doxylamine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Doxylamine—Malaise—Prednisone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Doxylamine—Vertigo—Prednisone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Doxylamine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Doxylamine—Anorexia—Dexamethasone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Doxylamine—Anorexia—Betamethasone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Doxylamine—Urticaria—Prednisolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Doxylamine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Doxylamine—Fatigue—Triamcinolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Doxylamine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Doxylamine—Hypotension—Dexamethasone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Doxylamine—Hypotension—Betamethasone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Doxylamine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Doxylamine—Convulsion—Prednisone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Doxylamine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Doxylamine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Doxylamine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Doxylamine—Anxiety—Prednisone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Doxylamine—Insomnia—Betamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Doxylamine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Doxylamine—Discomfort—Prednisone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Doxylamine—Erythema—Methotrexate—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Doxylamine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Doxylamine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Doxylamine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Doxylamine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Doxylamine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Doxylamine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Doxylamine—Fatigue—Dexamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Doxylamine—Fatigue—Betamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Doxylamine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Doxylamine—Tachycardia—Prednisone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Doxylamine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Doxylamine—Anorexia—Prednisone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Doxylamine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Doxylamine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Doxylamine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Doxylamine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Doxylamine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Doxylamine—Malaise—Methotrexate—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Doxylamine—Vertigo—Methotrexate—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Doxylamine—Leukopenia—Methotrexate—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Doxylamine—Urticaria—Betamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Doxylamine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Doxylamine—Dizziness—Prednisolone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Doxylamine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Doxylamine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Doxylamine—Insomnia—Prednisone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Doxylamine—Pruritus—Triamcinolone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Doxylamine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Doxylamine—Convulsion—Methotrexate—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Doxylamine—Decreased appetite—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Doxylamine—Rash—Prednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Doxylamine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Doxylamine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Doxylamine—Fatigue—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Doxylamine—Discomfort—Methotrexate—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Doxylamine—Constipation—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Doxylamine—Confusional state—Methotrexate—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Doxylamine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Doxylamine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Doxylamine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Doxylamine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Doxylamine—Asthenia—Betamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Doxylamine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Doxylamine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Doxylamine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Doxylamine—Nausea—Prednisolone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Doxylamine—Pruritus—Betamethasone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Doxylamine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Doxylamine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Doxylamine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Doxylamine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Doxylamine—Rash—Triamcinolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Doxylamine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Doxylamine—Anorexia—Methotrexate—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Doxylamine—Rash—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Doxylamine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Doxylamine—Urticaria—Prednisone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Doxylamine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Doxylamine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Doxylamine—Hypotension—Methotrexate—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Doxylamine—Dizziness—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Doxylamine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Doxylamine—Insomnia—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Doxylamine—Nausea—Triamcinolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Doxylamine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Doxylamine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Doxylamine—Somnolence—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Doxylamine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Doxylamine—Vomiting—Betamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Doxylamine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Doxylamine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Doxylamine—Rash—Dexamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Doxylamine—Rash—Betamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Doxylamine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Doxylamine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Doxylamine—Fatigue—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Doxylamine—Asthenia—Prednisone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Doxylamine—Pruritus—Prednisone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Doxylamine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Doxylamine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Doxylamine—Nausea—Dexamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Doxylamine—Nausea—Betamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Doxylamine—Urticaria—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Doxylamine—Dizziness—Prednisone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Doxylamine—Vomiting—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Doxylamine—Rash—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Doxylamine—Dermatitis—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Doxylamine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Doxylamine—Asthenia—Methotrexate—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Doxylamine—Nausea—Prednisone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Doxylamine—Pruritus—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Doxylamine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Doxylamine—Dizziness—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Doxylamine—Vomiting—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Doxylamine—Rash—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Doxylamine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Doxylamine—Nausea—Methotrexate—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
